214 related articles for article (PubMed ID: 37442413)
1. Unraveling the Enzyme-Substrate Properties for APOBEC3A-Mediated RNA Editing.
Kim K; Shi AB; Kelley K; Chen XS
J Mol Biol; 2023 Sep; 435(17):168198. PubMed ID: 37442413
[TBL] [Abstract][Full Text] [Related]
2. Creating RNA Specific C-to-U Editase from APOBEC3A by Separation of Its Activities on DNA and RNA Substrates.
Tang G; Xie B; Hong X; Qin H; Wang J; Huang H; Hao P; Li X
ACS Synth Biol; 2021 May; 10(5):1106-1115. PubMed ID: 33938211
[TBL] [Abstract][Full Text] [Related]
3. Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities.
Bulliard Y; Narvaiza I; Bertero A; Peddi S; Röhrig UF; Ortiz M; Zoete V; Castro-Díaz N; Turelli P; Telenti A; Michielin O; Weitzman MD; Trono D
J Virol; 2011 Feb; 85(4):1765-76. PubMed ID: 21123384
[TBL] [Abstract][Full Text] [Related]
4. Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.
Thielen BK; McNevin JP; McElrath MJ; Hunt BV; Klein KC; Lingappa JR
J Biol Chem; 2010 Sep; 285(36):27753-66. PubMed ID: 20615867
[TBL] [Abstract][Full Text] [Related]
5. Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions.
Silvas TV; Hou S; Myint W; Nalivaika E; Somasundaran M; Kelch BA; Matsuo H; Kurt Yilmaz N; Schiffer CA
Sci Rep; 2018 May; 8(1):7511. PubMed ID: 29760455
[TBL] [Abstract][Full Text] [Related]
6. APOBEC3A is implicated in a novel class of G-to-A mRNA editing in WT1 transcripts.
Niavarani A; Currie E; Reyal Y; Anjos-Afonso F; Horswell S; Griessinger E; Luis Sardina J; Bonnet D
PLoS One; 2015; 10(3):e0120089. PubMed ID: 25807502
[TBL] [Abstract][Full Text] [Related]
7. AID, APOBEC3A and APOBEC3B efficiently deaminate deoxycytidines neighboring DNA damage induced by oxidation or alkylation.
Diamond CP; Im J; Button EA; Huebert DNG; King JJ; Borzooee F; Abdouni HS; Bacque L; McCarthy E; Fifield H; Berghuis LM; Larijani M
Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129415. PubMed ID: 31404619
[TBL] [Abstract][Full Text] [Related]
8. Single-stranded DNA binding proteins influence APOBEC3A substrate preference.
Brown AL; Collins CD; Thompson S; Coxon M; Mertz TM; Roberts SA
Sci Rep; 2021 Oct; 11(1):21008. PubMed ID: 34697369
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3A is a prominent cytidine deaminase in breast cancer.
Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
[TBL] [Abstract][Full Text] [Related]
10. A DNA sequence recognition loop on APOBEC3A controls substrate specificity.
Logue EC; Bloch N; Dhuey E; Zhang R; Cao P; Herate C; Chauveau L; Hubbard SR; Landau NR
PLoS One; 2014; 9(5):e97062. PubMed ID: 24827831
[TBL] [Abstract][Full Text] [Related]
11. APOBEC3A Loop 1 Is a Determinant for Single-Stranded DNA Binding and Deamination.
Ziegler SJ; Hu Y; Devarkar SC; Xiong Y
Biochemistry; 2019 Sep; 58(37):3838-3847. PubMed ID: 31448897
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties.
Mitra M; Hercík K; Byeon IJ; Ahn J; Hill S; Hinchee-Rodriguez K; Singer D; Byeon CH; Charlton LM; Nam G; Heidecker G; Gronenborn AM; Levin JG
Nucleic Acids Res; 2014 Jan; 42(2):1095-110. PubMed ID: 24163103
[TBL] [Abstract][Full Text] [Related]
13. APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.
Ooms M; Krikoni A; Kress AK; Simon V; Münk C
J Virol; 2012 Jun; 86(11):6097-108. PubMed ID: 22457529
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme.
Caval V; Bouzidi MS; Suspène R; Laude H; Dumargne MC; Bashamboo A; Krey T; Vartanian JP; Wain-Hobson S
Nucleic Acids Res; 2015 Oct; 43(19):9340-9. PubMed ID: 26384561
[TBL] [Abstract][Full Text] [Related]
15. Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA.
Caval V; Jiao W; Berry N; Khalfi P; Pitré E; Thiers V; Vartanian JP; Wain-Hobson S; Suspène R
BMC Genomics; 2019 Nov; 20(1):858. PubMed ID: 31726973
[TBL] [Abstract][Full Text] [Related]
16. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions.
Henry M; Terzian C; Peeters M; Wain-Hobson S; Vartanian JP
PLoS One; 2012; 7(1):e30036. PubMed ID: 22272271
[TBL] [Abstract][Full Text] [Related]
18. The Base-Editing Enzyme APOBEC3A Catalyzes Cytosine Deamination in RNA with Low Proficiency and High Selectivity.
Barka A; Berríos KN; Bailer P; Schutsky EK; Wang T; Kohli RM
ACS Chem Biol; 2022 Mar; 17(3):629-636. PubMed ID: 35262324
[TBL] [Abstract][Full Text] [Related]
19. Efficient deamination of 5-methylcytidine and 5-substituted cytidine residues in DNA by human APOBEC3A cytidine deaminase.
Suspène R; Aynaud MM; Vartanian JP; Wain-Hobson S
PLoS One; 2013; 8(6):e63461. PubMed ID: 23840298
[TBL] [Abstract][Full Text] [Related]
20. Programmable C-to-U RNA editing using the human APOBEC3A deaminase.
Huang X; Lv J; Li Y; Mao S; Li Z; Jing Z; Sun Y; Zhang X; Shen S; Wang X; Di M; Ge J; Huang X; Zuo E; Chi T
EMBO J; 2020 Nov; 39(22):e104741. PubMed ID: 33058229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
